The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer
- 1 May 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (10) , 1534-1542
- https://doi.org/10.1038/bjc.1997.262
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Containing Costs While Improving Quality of Care: The Role of Profiling and Practice GuidelinesAnnual Review of Public Health, 1993
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- The Impact of Patient Management Guidelines on the Care of Breast, Colorectal, and Ovarian Cancer Patients in ItalyMedical Care, 1991
- Attitudes and practices regarding adjuvant chemotherapy in node-negative breast cancerJournal of Cancer Education, 1990
- Adjuvant Therapy of Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- An application of capture-recapture methods to the estimation of completeness of cancer registrationJournal of Clinical Epidemiology, 1988
- When Does Information Change Practitioners' Behavior?International Journal of Technology Assessment in Health Care, 1988